NCT03271255 2019-01-23
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)
Shenzhen People's Hospital
Phase 2 Unknown
Shenzhen People's Hospital
Epidemiological and Clinical Research Information Network
Sun Yat-sen University